close icon

AMD Stock Carries More Risk than Reward near $25

AMD stock is up almost 34% since the start of 2019, beating the year-to-date return of the S&P 500 three times over. Shares fell to $16.04 on December 26th, when the bulls finally managed to fight back. Yesterday, the stock closed at $24.71, following an intraday high of $25.51.

Most people, anticipating the rally to continue, would often buy a stock after it has risen substantially. But as Warren Buffett once put it, “the investor of today does not profit from yesterday’s growth.” So let’s take a look at AMD through an Elliott Wave perspective and see if it is still a good stock to pick up for 2019.

Elliott Wave analysis of AMD stock suggests it is vulnerable

The 2-hour chart shows that the sharp selloff from $34.14 to $16.17 can actually be seen as a textbook five-wave impulse in wave (A), whose wave 5 is extended.

According to the Elliott Wave theory, a three-wave correction in the opposite direction follows every impulse pattern. And indeed, the rest of the chart reveals an A-B-C expanding flat correction in wave (B) up to $25.51 so far.

If this count is correct, there is a complete 5-3 cycle to the south from the September 2018 top at $34.14. Unfortunately for AMD shareholders, this means another decline to under $16 a share can be expected in wave (C) down from now on.

The MACD indicator further supports the negative outlook. It shows a bearish divergence between waves iii and v of C of (B), highlighting the bulls’ hidden vulnerability near the 50% Fibonacci level. In our opinion, this is definitely not the time to join the bulls in AMD stock.

Did you like this analysis? Our Elliott Wave Video Course can teach you how to uncover the patterns yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

T Rowe Price Vulnerable After Fibonacci Encounter

Founded in 1937 and based in Baltimore, Maryland, T Rowe Price is one of the largest asset management companies in the world. At the end of Q1 2019 its assets under management stood at $1.11T. That is T for trillion. Besides, T Rowe Price is also a public company which is why it is of…

Read More »

Momo Inc. – The Tinder of China Looks Promising

Based in Beijing, China, Momo Inc. operates a mobile-based social and entertainment platform. The company was founded in 2011 and became public in late-2014. The Tinder of China, as Momo is often referred to, first turned a profit in 2015 and has been enjoying strong earnings and revenue growth in the last three years. Momo…

Read More »

TTD Stock: Don’t Let that 8-fold Surge Seduce You

The Trade Desk Inc. provides a self-service omni-channel software platform enabling clients to purchase and manage data-driven digital advertising campaigns. TTD stock is trading on NASDAQ since September 2016. In less than three years, the shares have surged from the IPO price of $28.75 to over $232 earlier this month. Early investors have managed to…

Read More »

Mondi Group: Little Known Firm, Well Known Pattern

Even Mondi Group themselves acknowledge that not too many people have heard their name. “Our name may not be familiar to the public, but our products are” is written on the second page of the company’s 2018 annual report. Mondi, listed on the London Stock Exchange, is a global paper and packaging company, headquartered in…

Read More »

Swedbank to Benefit from a Bullish Elliott Wave Cycle

It took Swedbank, one of Sweden’s biggest financial institutions, ten years to return to its pre-crisis glory. The stock rose from as low as SEK 14.70 in March 2009 to SEK 234 in February 2017 – less than SEK 2 below its February 2007 peak. And just when it looked like a new all-time high…

Read More »

FOSL Stock Ready to Exceed Expectations?

In October 2013, Fossil Group had a market cap of roughly $7.5 billion. The watchmaker was enjoying record sales and profits, which was supposed to propel FOSL stock, then hovering above $130 a share, even higher. Fast-forward six years and the company is currently valued at less than $650 million with the shares barely above…

Read More »

Bristol-Myers: Elliott Wave Setup can Double the Price

Bristol-Myers Squibb is in the process of acquiring Celgene in a $74 billion dollar cash-and-stock deal including debt. The deal faced opposition from hedge funds Wellington Management and Starboard Value, but ultimately gained shareholder approval on April 12th. Arbitrageurs, who aim to profit from the discrepancy between the market price and the deal closing price,…

Read More »

More analyses